Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis

被引：0
|
作者：
Larissa Schwarzkopf
Sabine Witt
Julia Waelscher
Markus Polke
Michael Kreuter
机构：
[1] Comprehensive Pneumology Center Munich (CPC-M),Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Institute of Health Economics and Health Care Management
[2] Member of the German Center for Lung Research (DZL),Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik
[3] University of Heidelberg,undefined
[4] Translational Lung Research Center Heidelberg (TLRC),undefined
[5] Member of the German Center for Lung Research (DZL),undefined
来源：
Respiratory Research | / 19卷
关键词：
Administrative data; Pharmaceutical management; Drugs; Mortality; Diffuse parenchymal lung disease; Multi-morbidity; Germany; Statutory Health Insurance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Survival Analysis of Patients with Interstitial Lung Disease and Acute Respiratory Failure
    Jurado Camacho, L. F.
    Rojas-Serrano, J.
    Goytia, L.
    Mejia, M.
    Hernandez, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [42] A SINGLE CENTRE RETROSPECTIVE SURVIVAL ANALYSIS OF PATIENTS WITH INTERSTITIAL LUNG DISEASE
    Bradshaw, T.
    Roychoudhury, A.
    Bianchi, S. M.
    THORAX, 2012, 67 : A119 - A119
  • [43] Correlation between Transthoracic Lung Ultrasound Score and HRCT Features in Patients with Interstitial Lung Diseases
    Man, Milena Adina
    Dantes, Elena
    Hancu, Bianca Domokos
    Bondor, Cosmina Ioana
    Ruscovan, Alina
    Parau, Adriana
    Motoc, Nicoleta Stefania
    Marc, Monica
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [44] Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series
    Manfredi, A.
    Sebastiani, M.
    Cassone, G.
    Colaci, M.
    Sandri, G.
    Ferri, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : 342 - 342
  • [45] PREDICTORS OF TREATMENT OUTCOME IN PATIENTS WITH INTERSTITIAL LUNG DISEASES IN A TERTIARY CARE CENTRE
    Ronaldwin, B.
    Kamala, R.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (61): : 4312 - 4315
  • [46] Chitotriosidase activity in patients with interstitial lung diseases
    Bargagli, Elena
    Margollicci, Maria
    Luddi, Alice
    Nikiforakis, Nicolaos
    Perari, Maria Grazia
    Grosso, Salvatore
    Perrone, Anna
    Rottoli, Paola
    RESPIRATORY MEDICINE, 2007, 101 (10) : 2176 - 2181
  • [47] MicroRNAs in serum of Interstitial lung diseases patients
    Shepelkova, Galina
    Evstifeev, Vladimir
    Zaytseva, Anna
    Adamovskaya, Evgenia
    Guskov, Alexander
    Stepanyan, Igor
    Shmelev, Evgeniy
    Yeremeev, Vladimir
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [48] Clubbing in patients with fibrotic interstitial lung diseases
    van Manen, M. J. G.
    Vermeer, L. C.
    Moor, C. C.
    Vrijenhoeff, R.
    Grutters, J. C.
    Veltkamp, M.
    Wijsenbeek, M. S.
    RESPIRATORY MEDICINE, 2017, 132 : 226 - 231
  • [49] Pregnancy course in patients with interstitial lung diseases
    Novikova, Lubov
    Ilkovich, Yulia
    Dzadzua, Dali
    Korzina, Natalia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [50] Clubbing in patients with fibrotic interstitial lung diseases
    van Manen, Mirjam J. G.
    Vermeer, Laura C.
    Moor, C. C. Karen
    Vrijenhoeff, Robin
    Grutters, Jan C.
    Veltkamp, Marcel
    Wijsenbeek, Marlies S.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345